Sight Sciences Stock

sightsciences.comHealthcare / Medical DevicesFounded: 2010Funding to Date: $180MM

Sight Science was created in 2010, focusing on developing and commercializing innovative solutions to transform care and improve patients' lives. Targeting eye diseases and using minimally invasive or non-invasive approaches positively impacts a patient's sight. By implementing these techniques, Sight Sciences can address the underlying causes of the world's most prevalent eye disease.

Register To Buy and Sell Shares

For more details on financing and valuation for Sight Sciences, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in


Enterprise Value

Powered by Forge Data

Access Sight Sciences’ valuation and stock price.

View secondary pricing information, VWAP and distribution waterfall. And seek potentially outsized returns with same day private market data for private companies like Sight Sciences.

Become part of the Secondary Marketplace, catering to both individual and institutional investors.


Animation displayed is not current and securities are shown for illustrative purposes only.


Management Team

Jesse Selnick
Chief Financial Officer
Shawn O'Neil
Chief Commercial Officer
Paul Badawi
Co-Founder, President, Chief Executive Officer & Board Member
David Badawi MD
Co-Founder, Chief Technology Officer & Board Member
Reay Brown
Chief Medical Officer

Board Members

David Badawi MD
Valeska Schroeder Ph.D
Mack Hicks
Hicks Equity Partners
Paul Badawi
Carter Meyer JD
Scientific Health Development
Tommy Hicks

News Highlights

Sight Sciences Appoints Erica Rogers to its Board of Directors
Sight Sciences announced the appointment of Erica Rogers to the company’s board of directors. Ms. Rogers, President and CEO of Silk Road Medical, is an experienced leader and entrepr
Sight Sciences Raises $56M in Funding | FinSMEs
Sight Sciences, a medical device company focused on ophthalmology and optometry, glaucoma and dry eye disease, closed a $31m in Series D financing
Updated on: Apr 19, 2024


Public news articles listed on this page have been curated by Forge based on several factors including, but not limited to, product updates, changes in organization structure, funding rounds, third-party valuations, and key personnel changes. Changes to this list of articles can be made at any time without notice and should not be relied upon for investment purposes. Forge does not verify the accuracy of the information contained in public news articles.